FindMyKOL
Clinical trialNCT00587938CompletedObservational

BNP Measurement Reduces Resource Utilization for Patients With CHF Admitted Thorough the ED

NCT00587938 is an observational study sponsored by Mayo Clinic. As of 18 Nov 2026, it is completed. It studies Congestive Heart Failure. The registry lists an enrollment of 200 participants at 1 site in 1 country. The registry lists a start date of 31 Dec 2003 and a primary completion date of 31 Mar 2005.

SponsorMayo Clinic →Enrollment200Congestive Heart Failure
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT00587938
FieldValue
Registry IDNCT00587938
StatusCompleted
Study typeObservational study
Lead sponsorMayo Clinic
Enrollment200
Registered sites1
Countries1
ConditionsCongestive Heart Failure
Start31 Dec 2003
Primary completion31 Mar 2005
Study completion31 Mar 2005
Last update posted8 Jan 2008

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Measurement of brain natriuretic peptide (BNP) in dyspneic patients increases diagnostic accuracy for congestive heart failure (CHF). Limited information is available regarding economic outcomes attributable to BNP assay. The aim of this study was to assess the economic impact of BNP assay in elderly dyspneic patients presenting to the emergency department (ED).

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Minnesota, United States1 site
  • Saint Marys Hospital, Mayo Clinic

    Rochester

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesota: 1 siteMN1WisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT00587938

Each answer restates registry values shown on this page.

What is NCT00587938?

NCT00587938 is an observational study sponsored by Mayo Clinic. It studies Congestive Heart Failure.

Who leads NCT00587938?

The registry names Alfredo L Clavell, MD (principal investigator, Mayo Clinic), Lyle J Olsen, MD (study chair, Mayo Clinic), Paula J Santrach, MD (study director, Mayo Clinic) and 1 more official as overall officials.

Where does NCT00587938 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT00587938 end?

The registry lists a primary completion date of 31 Mar 2005 and a study completion date of 31 Mar 2005. The sponsor last updated the record on 8 Jan 2008.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.